| Predicate |
Object |
| contentType |
Journal Article|Research Support, Non-U.S. Gov't|Review |
| endingPage |
233 |
| issn |
1432-1440
0946-2716 |
| issueIdentifier |
3 |
| pageRange |
227-233 |
| publicationName |
Journal of molecular medicine (Berlin, Germany) |
| startingPage |
227 |
| bibliographicCitation |
Smink JJ, Leutz A. Rapamycin and the transcription factor C/EBPβ as a switch in osteoclast differentiation: implications for lytic bone diseases. Journal of Molecular Medicine. 2009 Nov 27;88(3):227–33. doi: 10.1007/s00109-009-0567-8. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0967605e4aba6884df87abef6dfac365
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f35a2b6be13944a57deef84e406ff1b2 |
| date |
2009-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/19943027
https://doi.org/10.1007/s00109-009-0567-8
https://pubmed.ncbi.nlm.nih.gov/PMC2836244 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/8748
https://portal.issn.org/resource/ISSN/0946-2716
https://portal.issn.org/resource/ISSN/1432-1440 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/ |
| title |
Rapamycin and the transcription factor C/EBPbeta as a switch in osteoclast differentiation: implications for lytic bone diseases |
| discusses |
http://id.nlm.nih.gov/mesh/M0029863
http://id.nlm.nih.gov/mesh/M0164346 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8729
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8738
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7073
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_85be224aa48f1786b1036470a769ce24 |